ClinicalTrials.govpublic full text
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
locally advanced non-small cell lung cancer, efficacy and safety
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 411409
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.